ArticleOncology letters2018

Estrogen receptor-α promoter methylation is a biomarker for outcome prediction of cisplatin resistance in triple-negative breast cancer.

Junnan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.